Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
Carolina Beltrán-Pavez, Sebastián Riquelme-Barrios, Aarón Oyarzún-Arrau, et al.
Science Advances (2021) Vol. 7, Iss. 7
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes
Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 89
Safety and Immunogenicity of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Subgroup of Healthy Adults in Chile
Susan M. Bueno, Katia Abarca, Pablo A. González, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e792-e804
Open Access | Times Cited: 99
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
María Elvira Balcells, Luis Rojas, Nicole Le Corre, et al.
PLoS Medicine (2021) Vol. 18, Iss. 3, pp. e1003415-e1003415
Open Access | Times Cited: 89
Infectivity and immune escape of the new SARS-CoV-2 variant of interest Lambda
Mónica L. Acevedo, Luis Alonso-Palomares, Andrés Bustamante, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 79
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial
Susan M. Bueno, Katia Abarca, Pablo A. González, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 56
Screening of Natural Products Inhibitors of SARS-CoV-2 Entry
Pamela González-Maldonado, Nelson Alvarenga, Alberto Burgos-Edwards, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1743-1743
Open Access | Times Cited: 31
Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, et al.
Nature Microbiology (2022) Vol. 7, Iss. 4, pp. 524-529
Open Access | Times Cited: 29
A Live-Cell Imaging-Based Fluorescent SARS-CoV-2 Neutralization Assay by Antibody-Mediated Blockage of Receptor Binding Domain-ACE2 Interaction
Jorge L. Arias-Arias, Laura Monturiol‐Gross, Eugenia Corrales‐Aguilar
BioTech (2025) Vol. 14, Iss. 1, pp. 10-10
Open Access
COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study
Denis Sauré, Miguel O’Ryan, Juan Pablo Torres, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 3, pp. e149-e158
Open Access | Times Cited: 14
IgA, IgM, and IgG Antibodies and Neutralizing Activity against SARS-CoV-2 in a Population of Colombian Healthcare Workers and Hospital Staff
Norma C. Serrano, Claudia Carolina Colmenares Mejía, Doris Cristina Quintero-Lesmes, et al.
Revista de Investigación e Innovación en Ciencias de la Salud (2025) Vol. 7, Iss. 2
Open Access
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 20
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, et al.
EBioMedicine (2023) Vol. 91, pp. 104563-104563
Open Access | Times Cited: 11
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies
Leonardo Vargas, Nicolás Valdivieso, Fabián Tempio, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 17
Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group
Alejandro Escobar, Felipe E. Reyes‐López, Mónica L. Acevedo, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 16
A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept
José Antonio Cruz-Cardenas, Michelle Gutiérrez, Alejandra López-Arredondo, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Phytochemical Discrimination, Biological Activity and Molecular Docking of Water-Soluble Inhibitors from Saussurea costus Herb against Main Protease of SARS-CoV-2
Hajo Idriss, Babeker Siddig, Pamela González-Maldonado, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4908-4908
Open Access | Times Cited: 14
Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
Francisco Fuentes‐Villalobos, José Luis Velasco Garrido, Matías A. Medina, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients
Aracelly Gaete-Argel, Vicente Saavedra-Alarcón, Denis Sauré, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Nicolás M. S. Gálvez, Gaspar A. Pacheco, Bárbara M. Schultz, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 10
Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach
Alexander Kwarteng, Ebenezer Asiedu, Augustina Angelina Sylverken, et al.
Infection Genetics and Evolution (2021) Vol. 91, pp. 104815-104815
Open Access | Times Cited: 13
Unraveling the antiviral activity of Stachytarpheta cayennensis against SARS-CoV-2 variants using in vitro and molecular docking analysis
Nelson Alvarenga, Dionisio A. Olmedo, Pamela González-Maldonado, et al.
South African Journal of Botany (2024) Vol. 169, pp. 567-575
Closed Access | Times Cited: 1
SARS-CoV-2 infectivity and antigenic evasion: spotlight on isolated Omicron sub-lineages
Aldo Barrera, Constanza Martínez-Valdebenito, Jenniffer Angulo, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
Jorge A. Soto, Felipe Melo-González, Cristián Gutiérrez-Vera, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Development of a Rapid Fluorescent Diagnostic System for Early Detection of the Highly Pathogenic Avian Influenza H5 Clade 2.3.4.4 Viruses in Chicken Stool
Bao Tuan Duong, Duc-Duong Than, Bae-Gum Ju, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6301-6301
Open Access | Times Cited: 6
Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
Roxana González‐Stegmaier, Karina Cereceda, José Luis Teruel Briones, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top